← All stocks

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB Net selling
CIK 0001299130 #3300 in the set updated 17 Sep 2026
Bought (120 mo)
$176.16K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$181.23M
$409.52K on a plan · $118.25M straight out of an exercise
Sold at will
$62.57M
86 of 153 sales
Net
−$181.05M
−$62.39M against sales at will

By person

23 insiders · 172 transactions
5.4×

Christian O. Henry holds 5.4 times base salary in stock. $4.05M of shares against $748.25K in salary for 2025.

Salary from the company's own proxy. The shares are what Christian O. Henry last reported holding, valued at $1.13, the price Common Stock was last bought or sold at on the open market here, on 17 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hunkapiller Michael
Director
$140.92M (71) scheduled
−$140.92M
848,405
0.2729%
$958.70K
−79.9%
ORDONEZ KATHY
Director
$10.87M (6) scheduled
−$10.87M
403,037
0.1297%
$455.43K
Botstein David
Director
$7.94M (2) scheduled
−$7.94M
0
0.0000%
$0.00
HENRY CHRISTIAN O
See Remarks
$7.01M (19)
−$7.01M
3,581,813
1.15%
$4.05M
Shapiro Lucy
Director
$5.12M (1)
−$5.12M
22,821
0.0073%
$25.79K
−77.6%
LIVINGSTON RANDALL S
Director
$3.24M (1) scheduled
−$3.24M
22,821
0.0073%
$25.79K
Van Oene Mark
See Remarks
$2.38M (16)
−$2.38M
2,705,853
0.8705%
$3.06M
+8,194%
Ericson William W.
Director
$1.04M (3) scheduled
−$1.04M
41,616
0.0134%
$47.03K
−99.3%
Kim Susan G.
See Remarks
$1.02M (10)
−$1.02M
695,654
0.2238%
$786.09K
+6,617%
Eidel Jeff
See Remarks
$409.78K (3)
−$409.78K
869,730
0.2798%
$982.79K
+7,037%
Farmer Michele
See Remarks
$324.47K (12)
−$324.47K
305,948
0.0984%
$345.72K
+3,069%
Fromen Peter
See Remarks
$282.00K (1)
−$282.00K
190,280
0.0612%
$215.02K
Phillips James Michael
SVP, Research & Development
$251.58K (4) scheduled
−$251.58K
249,220
0.0802%
$281.62K
+24.5%
Meline David W
Director
$176.16K (1)
+$176.16K
57,116
0.0184%
$64.54K
Schaefer Eric
Chief Accounting Officer
$150.61K (1)
−$150.61K
88,474
0.0285%
$99.98K
+1.4%
BARNES SUSAN K
EVP, CFO and PAO
$141.61K (2)
−$141.61K
874,812
0.2814%
$988.54K
+1,129%
Gibson James R II
See Remarks
$120.81K (1)
−$120.81K
1,245,663
0.4008%
$1.41M
CORCORAN KEVIN P
SVP, Market Development
158,174
0.0509%
$178.74K
+246.3%
MOHR MARSHALL
Director
132,821
0.0427%
$150.09K
MILLIGAN JOHN F
Director
132,821
0.0427%
$150.09K
Gibson Christopher
Director
111,386
0.0358%
$125.87K
Smith Christopher M
Director
54,099
0.0174%
$61.13K
Valantine Hannah
Director
22,821
0.0073%
$25.79K
Insider
Date
Role
Action
Shares
Price
Amount
ORDONEZ KATHY
15 Mar 2024
Director
Exercised, kept
37,106
$2.63
$97.59K
ORDONEZ KATHY
15 Mar 2024
Director
Exercised, kept
324,515
$2.90
$941.09K
MOHR MARSHALL
1 Mar 2024
Director
Exercised, kept
25,000
$4.45
$111.25K
MOHR MARSHALL
18 May 2023
Director
Exercised, kept
25,000
$2.54
$63.50K
MOHR MARSHALL
10 Jun 2022
Director
Exercised, kept
35,000
$1.83
$64.05K
MOHR MARSHALL
14 Jan 2022
Director
Exercised, kept
25,000
$3.57
$89.25K
MILLIGAN JOHN F
24 Aug 2020
Director
Exercised, kept
25,000
$2.61
$65.25K
MILLIGAN JOHN F
24 Aug 2020
Director
Exercised, kept
25,000
$3.81
$95.25K
MILLIGAN JOHN F
24 Aug 2020
Director
Exercised, kept
25,000
$4.45
$111.25K
MILLIGAN JOHN F
24 Aug 2020
Director
Exercised, kept
35,000
$2.67
$93.45K
BARNES SUSAN K
20 Dec 2018
EVP, CFO and PAO
Exercised, kept
18,228
$2.63
$47.94K
BARNES SUSAN K
20 Dec 2018
EVP, CFO and PAO
Exercised, kept
48,762
$2.27
$110.69K
BARNES SUSAN K
20 Dec 2018
EVP, CFO and PAO
Exercised, kept
250,000
$4.79
$1.20M
CORCORAN KEVIN P
24 Nov 2017
SVP, Market Development
Exercised, kept
256
$1.96
$501.76
CORCORAN KEVIN P
20 Jul 2017
SVP, Market Development
Exercised, kept
28,061
$1.96
$55.00K
CORCORAN KEVIN P
14 Jun 2017
SVP, Market Development
Exercised, kept
84,183
$1.96
$165.00K
BARNES SUSAN K
2 Jun 2017
EVP, CFO and PAO
Exercised, kept
276,238
$2.27
$627.06K
Hunkapiller Michael
1 Jun 2017
Chairman, CEO & President
Exercised, kept
500,000
$3.01
$1.51M

What was left out

Form 4 filings counted 222
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 64
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 23,656,552
Sales filed before the plan box existed 44
History held since 31 Oct 2016